[1]
|
Jemal, A., Bray, F., Center, M.M., Ferly, J., Ward, E. and Forman, D. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. http://dx.doi.org/10.3322/caac.20107
|
[2]
|
Kanavos, P. (2006) The Rising Burden of Cancer in the Developing World. Annals of Oncology, 17, viii15-viii23.
|
[3]
|
European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. Journal of Hepatology, 56, 908-943.
|
[4]
|
Al-Faleh, F.Z., Al-Jeffri, M., Ramia, S., Al-Rashed, R., Arif, M., Rezeig, M., Al-Toraif, I., Baksh, M., Mishkkhas, A., Makki, O., Al-Freihi, H., Mirdad, S., Al-Juma, A, Yasin, T., Al-Swailem, A. and Ayoola, A. (1999) Seroepidemiology of Hepatitis B Infection in Saudi Children 8 Years after a Mass Hepatitis B Vaccination Programme. Journal of Infection, 38, 167-170. http://dx.doi.org/10.1016/S0163-4453(99)90245-1
|
[5]
|
Koriech, O.M. and Al-Kuhaymi R. (1994) Profile of Cancer in Riyadh Armed Forces Hospital. Annals of Saudi Medicine, 14, 187-194.
|
[6]
|
Al-Eid, H.S. and Garcia, A.D. (2014) Cancer Incidence Report Saudi Arabia 2009.
http://www.scr.org.sa/
|
[7]
|
Al-Faleh, F.Z., Al-Shehri, S., Al-Ansari, S., Al-Jeffri, M., Al-Mazrou, Y., Shaffi, A. and Abdo, A.A. (2008) Long-Term Protection of Hepatitis B Vaccine 18 Years after Vaccination. Journal of Infection, 57, 404-409.
|
[8]
|
Al Ghamdi, S.S., Fallatah, H.I., Fetyani, D.M., Al-Mughales, J.A. and Gelaidan, A.T. (2013) Long-Term Efficacy of the Hepatitis B Vaccine in a High-Risk Group. Journal of Medical Virology, 85, 1518-1512.
http://dx.doi.org/10.1002/jmv.23658
|
[9]
|
Alswat, K.A., Sanai, F.M., Altuwaijri, M., Albenmousa, A., Almadi, M., Al-Hamoudi, W.K., and Abdo, A.A. (2013) Clinical Characteristics of Patients with Hepatocellular Carcinoma in a Middle Eastern Population. Hepatitis Monthly, 13, e7612. http://dx.doi.org/10.5812/hepatmon.7612
|
[10]
|
Madani, T.A. (2007) Hepatitis C Virus Infections Reported in Saudi Arabia over 11 Years of Surveillance. Annals of Saudi Medicine, 27, 191-194. http://dx.doi.org/10.4103/0256-4947.51500
|
[11]
|
Akbar, H.O., Al Ghamdi, A., Qattan, F., Fallatah, H.I. and Al Rumani, M. (2012) Chronic Hepatitis C in Saudiarabia: Three Years Local Experience in a University Hospital. Hepatitis Monthly, 12, e6178.
http://dx.doi.org/10.5812/hepatmon.6178
|
[12]
|
Trevisani, F., D’Intino, P.E., Caraceni, P., Pizzo, M., Stefanini, G.F., Mazziotti, A., Grazi, G.L., Gozzetti, G., Gasbarrini, G. and Bernardi, M. (1995) Etiologic Factors and Clinical Presentation of Hepatocellular Carcinoma. Differences between Cirrhotic and Noncirrhotic Italian Patient. Cancer, 75, 2220-2232.
http://dx.doi.org/10.1002/1097-0142(19950501)75:9<2220::AID-CNCR2820750906>3.0.CO;2-4
|
[13]
|
Di Bisceglie, A.M. (2002) Epidemiology and Clinical Presentation of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology, 13, S169-S171. http://dx.doi.org/10.1016/S1051-0443(07)61783-7
|
[14]
|
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A. and Gennari, L. (1996) Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis. The New England Journal of Medicine, 334, 693-700.
http://dx.doi.org/10.1056/NEJM199603143341104
|
[15]
|
Llovet, J.M., Brú, C. and Bruix, J. (1999) Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification. Seminars in Liver Disease, 19, 329-338. http://dx.doi.org/10.1055/s-2007-1007122
|
[16]
|
Yao, F.Y., Ferrell, L., Bass, N.M., Bacchetti, P., Ascher, N.L. and Roberts, J.P. (2002) Liver Transplantation for Hepatocellular Carcinoma: Comparison of the Proposed UCSF Criteria with the Milan Criteria and the Pittsburgh Modified TNM Criteria. Liver Transplantation, 8, 765-774. http://dx.doi.org/10.1053/jlts.2002.34892
|
[17]
|
Bruix, J. and Sherman, M. (2011) Management of Hepatocellular Carcinoma: An Update. Hepatology, 53, 1020-1022.
http://dx.doi.org/10.1002/hep.24199
|
[18]
|
Ioannou, G.N., Splan, M.F., Weiss, N.S., McDonald, G.B., Beretta, L. and Lee, S.P. (2007) Incidence and Predictors of Hepatocellular Carcinoma in Patients with Cirrhosis. Clinical Gastroenterology and Hepatology, 5, 938-945.
|
[19]
|
Mughal, T.I. and Patel, S.B. (1996) Hepatocellular Carcinoma: A Review of 140 Cases. Annals of Saudi Medicine, 16, 53-55.
|
[20]
|
Alsohaibani, F., Porter, G., Al-Ashgar, H., Walsh, M., Berry, R., Molinari, M. and Peltekian, K.M. (2011) Comparison of Cancer Care for Hepatocellular Carcinoma at Two Tertiary-Care Referral Centers from High and Low Endemic Regions for Viral Hepatitis. Journal of Gastrointestinal Cancer, 42, 228-235.
http://dx.doi.org/10.1007/s12029-010-9200-x
|
[21]
|
Nouh, M.S., Bashi, S.A., Laajam, M.A., Mofleh, I.A. and Al-Aska, A. (1990) Hepatitis B Virus vs Schistosomiasis and Hepatocellular Carcinoma in Saudi Arabia. East African Medical Journal, 67, 139-145.
|
[22]
|
Ayoola, E.A. and Gadour, M.O. (2004) Hepatocellular Carcinoma in Saudi Arabia: Role of Hepatitis B and C Infection. Journal of Gastroenterology and Hepatology, 19, 665-669. http://dx.doi.org/10.1111/j.1440-1746.2003.03334.x
|
[23]
|
Herbst, D.A. and Reddy, K.R. (2012) Risk Factors for Hepatocellular Carcinoma. Clinical Liver Disease, 1, 180-182.
http://dx.doi.org/10.1002/cld.111
|
[24]
|
Tan, C.H., Low, S.C. and Thng, C.H. (2011) APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. International Journal of Hepatology, 2011, Article ID: 519783.
http://dx.doi.org/10.4061/2011/519783
|
[25]
|
Sersté, T., Barrau, V., Ozenne, V., Vullierme, M.P., Bedossa, P., Farges, O., Valla, D.C., Vilgrain, V., Paradis, V. and Degos, F. (2012) Accuracy and Disagreement of Computed Tomography and Magnetic Resonance Imaging for the Diagnosis of Small Hepatocellular Carcinoma and Dysplastic Nodules: Role of Biopsy. Hepatology, 55, 800-806.
http://dx.doi.org/10.1002/hep.24746
|
[26]
|
Abdo, A.A., Hassanain, M., AlJumah, A., AlOlayan, A., Sanai, F.M., Alsuhaibani, H.A., Abdulkareem, H., Abdallah, K., AlMuaikeel, M., Al Saghier, M., Babatin, M., Kabbani, M., Bazarbashi, S., Metrakos, P. and Bruix, J., Saudi Association for the Study of Liver Diseases and Transplantation, Saudi Oncology Society (2012) Saudi Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma: Technical Review and Practice Guidelines. Annals of Saudi Medicine, 32, 174-199.
|
[27]
|
Lu, S.N., Wang, J.H., Liu, S.L., Hung, C.H., Chen, C.H., Tung, H.D., Chen, T.M., Huang, W.S., Lee, C.M., Chen, C.C. and Changchien, C.S. (2006) Thrombocytopenia as a Surrogate for Cirrhosis and a Marker for the Identification of Patients at High-Risk for Hepatocellular Carcinoma. Cancer, 107, 2212-2222.
|
[28]
|
Kubo, S., Tanaka, H., Shuto, T., Takemura, S., Yamamoto, T., Uenishi, T., Tanaka, S., Ogawa, M., Sakabe, K., Yamazaki, K. and Hirohashi, K. (2004) Correlation between Low Platelet Count and Multicentricity of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C. Hepatology Research, 30, 221-225.
http://dx.doi.org/10.1016/j.hepres.2004.10.005
|
[29]
|
Fallatah, H. (2014) Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology, 2014, Article ID: 357287. http://dx.doi.org/10.1155/2014/357287
|
[30]
|
Cabrera, R. (2012) Systemic Targeted Therapy beyond Sorafenib. Clinical Liver Disease, 1, 212-216.
http://dx.doi.org/10.1002/cld.128
|
[31]
|
Shiina, S., Tateishi, R., Arano, T., Uchino, K., Enooku, K., Nakagawa, H., Asaoka, Y., Sato, T., Masuzaki, R., Kondo, Y., Goto, T., Yoshida, H., Omata, M. and Koike, K. (2012) Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors. The American Journal of Gastroenterology, 107, 569-577.
http://dx.doi.org/10.1038/ajg.2011.425
|
[32]
|
Duvoux, C., Roudot-Thoraval, F., Decaens, T., Pessione, F., Badran, H., Piardi, T., Francoz, C., Compagnon, P., Vanlemmens, C., Dumortier, J., Dharancy, S., Gugenheim, J., Bernard, P.H., Adam, R., Radenne, S., Muscari, F., Conti, F., Hardwigsen, J., Pageaux, G.P., Chazouillères, O., Salame, E., Hilleret, M.N., Lebray, P., Abergel, A., Debette-Gratien, M., Kluger, M.D., Mallat, A., Azoulay, D. and Cherqui, D., Liver Transplantation French Study Group (2012) Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan criteria. Gastroenterology, 143, 986-994. http://dx.doi.org/10.1053/j.gastro.2012.05.052
|
[33]
|
Papatheodoridis, G.V., Chrysanthos, N., Savvas, S., Sevastianos, V., Kafiri, G., Petraki, K. and Manesis, E.K. (2006) Diabetes Mellitus in Chronic Hepatitis B and C: Prevalence and Potential Association with the Extent of Liver Fibrosis. Journal of Viral Hepatitis, 13, 303-310. http://dx.doi.org/10.1111/j.1365-2893.2005.00677.x
|
[34]
|
Al-Nozha, M.M., Al-Maatouq, M.A., Al-Mazrou, Y.Y., Al-Harthi, S.S., Arafah, M.R., Khalil, M.Z., Khan, N.B., Al-Khadra, A., Al-Marzouki, K., Nouh, M.S., Abdullah, M., Attas, O., Al-Shahid, M.S. and Al-Mobeireek, A. (2004) Diabetes Mellitus in Saudi Arabia. Saudi Medical Journal, 25, 1603-1610.
|
[35]
|
Abbas, Z., Siddiqui, A.U., Luck, N.H., Hassan, M., Mirza, R., Naqvi, A. and Rizvi, A.H. (2008) Prognostic Factors of Survival in Patients with Non-Resectable Hepatocellular Carcinoma: Hepatitis C versus Miscellaneous Etiology. Jour- nal of Pakistan Medical Association, 58, 602-607.
|
[36]
|
Yaghi, C., Sharara, A.I., Rassam, P., Moucari, R., Honein, K., BouJaoude, J., Slim, R., Noun, R., Abdul-Baki, H., Khalifeh, M., Ramia, S. and Sayegh, R. (2006) Hepatocellular Carcinoma in Lebanon: Etiology and Prognostic Factors Associated with Short-Term Survival. World Journal of Gastroenterology, 12, 3575-3580.
|
[37]
|
Paranaguá-Vezozzo, D.C., Ono, S.K., Alvarado-Mora, M.V., Farias, A.Q., Cunha-Silva, M., Fran?a, J.I., Alves, V.A., Sherman, M. and Carrilho, F.J. (2014) Epidemiology of HCC in Brazil: Incidence and Risk Factors in a Ten-Year Cohort. Annals of Hepatology, 13, 386-393.
|
[38]
|
Tateishi, R., Okanoue, T., Fujiwara, N., Okita, K., Kiyosawa, K., Omata, M., Kumada, H., Hayashi, N. and Koike, K. (2014) Clinical Characteristics, Treatment, and Prognosis of Non-B, Non-C Hepatocellular Carcinoma: A Large Retrospective Multicenter Cohort Study. Journal of Gastroenterology. (Published Online).
http://download.springer.com/static/pdf/32/art%253A10.1007%252Fs00535-014-0973-8.pdf?auth66=1413305494_df9385b19aa7645df3d09fef19f61057&ext=.pdf
|
[39]
|
Utsunomiya, T., Shimada. M., Kudo, M., Ichida, T., Matsui, O., Izumi, N., Matsuyama, Y., Sakamoto, M., Nakashima, O., Ku, Y., Kokudo, N. and Makuuchi, M., Liver Cancer Study Group of Japan (2014) Nationwide Study of 4741 Patients with Non-B Non-C Hepatocellular Carcinoma with Special Reference to the Therapeutic Impact. Annals of Surgery, 259, 336-345. http://dx.doi.org/10.1097/SLA.0b013e31829291e9
|